The US Food and Drug Administration (FDA) has approved zolmitriptan nasal spray (Zomig, Impax Specialty Pharma) for the acute treatment of migraine with or without aura in children 12 years of age and ...

Background and Objective: Oral zolmitriptan is highly effective in the acute treatment of migraine. However, nausea and vomiting during attacks may limit the usefulness of oral medications. An ...

NEW YORK (Reuters Health) - A nasal spray containing the drug zolmitriptan, which is known by the brand name Zomig, effectively relieves migraine headache in adolescents and is well tolerated, ...

The sole question on appeal was whether it would have been obvious to make zolmitriptan into a nasal spray. The Federal Circuit agreed with the district court that the prior art taught away from ...

ALLEGAN, Mich., Nov. 16, 2021 /PRNewswire/ -- Padagis today announced the first-to-market launch of an AB-rated generic version of Zomig® Nasal Spray. Zomig® Nasal Spray is distributed in a unique ...

WASHINGTON, Aug 27 (Reuters) - A nose spray made using AstraZeneca Plc's migraine drug Zomig can help patients with painful cluster headaches, U.S. researchers said on Monday. A study of 52 people ...

Zolmitriptan nasal spray, used to treat migraine headaches, also may be safe and effective in treating painful cluster headaches, according to an article posted online today that will appear in the ...

BRIDGEWATER, N.J., June 29, 2018 /PRNewswire/ -- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that a panel of three Circuit Judges of the U.S. Court of Appeals for the Federal Circuit has ...